Blue Bell Private Wealth Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,000
Closed -$62.9K 693
2023
Q1
$62.9K Hold
1,000
0.02% 214
2022
Q4
$53.2K Hold
1,000
0.02% 209
2022
Q3
$56K Hold
1,000
0.02% 200
2022
Q2
$72K Hold
1,000
0.02% 191
2022
Q1
$79K Hold
1,000
0.02% 181
2021
Q4
$101K Buy
+1,000
New +$99.8K 0.03% 163
2016
Q4
Sell
-1,000
Closed -$70K 391
2016
Q3
$70K Hold
1,000
0.04% 169
2016
Q2
$56K Hold
1,000
0.04% 203
2016
Q1
$61K Hold
1,000
0.04% 201
2015
Q4
$64K Hold
1,000
0.04% 189
2015
Q3
$67K Hold
1,000
0.05% 184
2015
Q2
$68K Hold
1,000
0.04% 182
2015
Q1
$55K Hold
1,000
0.03% 209
2014
Q4
$51K Hold
1,000
0.03% 225
2014
Q3
$37K Hold
1,000
0.02% 268
2014
Q2
$39K Hold
1,000
0.02% 250
2014
Q1
$38K Hold
1,000
0.03% 221
2013
Q4
$38K Buy
+1,000
New +$38.3K 0.03% 223

Other funds holding USNA

Blue Bell Private Wealth Management's USNA Position: Q2 2023 in Review

Blue Bell Private Wealth Management sold out of Usana Health Sciences (USNA) in Q2 2023, closing a stake of 1,000 shares — an estimated $62.9K sold.

Blue Bell Private Wealth Management first reported a position in USNA in Q4 2013 and held it in 18 quarters. The position peaked at $101K in Q4 2021. 169 funds tracked by Wall St. Rank hold USNA as of Q2 2023.

  • Blue Bell Private Wealth Management reported no remaining Usana Health Sciences position as of Q2 2023 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 1,000 Usana Health Sciences shares in Q2 2023, an estimated $62.9K.
  • Blue Bell Private Wealth Management first reported a position in Usana Health Sciences in Q4 2013 and held it in 18 quarters.
  • Blue Bell Private Wealth Management's Usana Health Sciences position peaked at $101K in Q4 2021.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2023.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2023, filed 8 Aug 2023.